Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword

Gliomas are the most common lethal tumors of the brain associated with a poor prognosis and increased resistance to chemo-radiotherapy. Circular RNAs (circRNAs), newly identified noncoding RNAs, have appeared as critical regulators of therapeutic resistance among multiple cancers and gliomas. Since...

Full description

Saved in:
Bibliographic Details
Main Authors: Negin Masoomabadi, Ali Gorji, Tahereh Ghadiri, Safieh Ebrahimi
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-01-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:https://ijbms.mums.ac.ir/article_25003_30e0ec7bebb9991d7d60d418fd7b74b0.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850068359128809472
author Negin Masoomabadi
Ali Gorji
Tahereh Ghadiri
Safieh Ebrahimi
author_facet Negin Masoomabadi
Ali Gorji
Tahereh Ghadiri
Safieh Ebrahimi
author_sort Negin Masoomabadi
collection DOAJ
description Gliomas are the most common lethal tumors of the brain associated with a poor prognosis and increased resistance to chemo-radiotherapy. Circular RNAs (circRNAs), newly identified noncoding RNAs, have appeared as critical regulators of therapeutic resistance among multiple cancers and gliomas. Since circRNAs are aberrantly expressed in glioma and may act as promoters or inhibitors of therapeutic resistance, we categorized alterations of these specific RNAs expression in therapy resistant-glioma in three different classes, including chemoresistance, radioresistance, and glioma stem cell (GSC)-regulation. circRNAs act as competing endogenous RNA, sponging target microRNA and consequently affecting the expression of genes related to glioma tumorigenesis and resistance. By doing so, circRNAs can modulate the critical cellular pathways and processes regulating glioma resistance, including DNA repair pathways, GSC, epithelial-mesenchymal transition, apoptosis, and autophagy. Considering the poor survival and increased resistance to currently approved treatments for glioma, it is crucial to increase the knowledge of the resistance regulatory effects of circRNAs and their underlying molecular mechanisms. Herein, we conducted a comprehensive search and discussed the existing knowledge regarding the important role eof circRNAs in the emergence of resistance to therapeutic interventions in glioma. This knowledge may serve as a basis for enhancing the effectiveness of glioma therapeutic strategies.
format Article
id doaj-art-1bcde79ce6614d7783b3afeacce8e27e
institution DOAJ
issn 2008-3866
2008-3874
language English
publishDate 2025-01-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj-art-1bcde79ce6614d7783b3afeacce8e27e2025-08-20T02:48:06ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742025-01-0128131510.22038/ijbms.2024.81644.1766925003Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged swordNegin Masoomabadi0Ali Gorji1Tahereh Ghadiri2Safieh Ebrahimi3Department of Neuroscience and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, IranDepartment of Neuroscience and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, IranGliomas are the most common lethal tumors of the brain associated with a poor prognosis and increased resistance to chemo-radiotherapy. Circular RNAs (circRNAs), newly identified noncoding RNAs, have appeared as critical regulators of therapeutic resistance among multiple cancers and gliomas. Since circRNAs are aberrantly expressed in glioma and may act as promoters or inhibitors of therapeutic resistance, we categorized alterations of these specific RNAs expression in therapy resistant-glioma in three different classes, including chemoresistance, radioresistance, and glioma stem cell (GSC)-regulation. circRNAs act as competing endogenous RNA, sponging target microRNA and consequently affecting the expression of genes related to glioma tumorigenesis and resistance. By doing so, circRNAs can modulate the critical cellular pathways and processes regulating glioma resistance, including DNA repair pathways, GSC, epithelial-mesenchymal transition, apoptosis, and autophagy. Considering the poor survival and increased resistance to currently approved treatments for glioma, it is crucial to increase the knowledge of the resistance regulatory effects of circRNAs and their underlying molecular mechanisms. Herein, we conducted a comprehensive search and discussed the existing knowledge regarding the important role eof circRNAs in the emergence of resistance to therapeutic interventions in glioma. This knowledge may serve as a basis for enhancing the effectiveness of glioma therapeutic strategies.https://ijbms.mums.ac.ir/article_25003_30e0ec7bebb9991d7d60d418fd7b74b0.pdfcancer therapychemoresistancecircrnasdrug resistanceglioblastomagliomanoncoding rnaradioresistance
spellingShingle Negin Masoomabadi
Ali Gorji
Tahereh Ghadiri
Safieh Ebrahimi
Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword
Iranian Journal of Basic Medical Sciences
cancer therapy
chemoresistance
circrnas
drug resistance
glioblastoma
glioma
noncoding rna
radioresistance
title Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword
title_full Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword
title_fullStr Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword
title_full_unstemmed Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword
title_short Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword
title_sort regulatory role of circular rnas in the development of therapeutic resistance in the glioma a double edged sword
topic cancer therapy
chemoresistance
circrnas
drug resistance
glioblastoma
glioma
noncoding rna
radioresistance
url https://ijbms.mums.ac.ir/article_25003_30e0ec7bebb9991d7d60d418fd7b74b0.pdf
work_keys_str_mv AT neginmasoomabadi regulatoryroleofcircularrnasinthedevelopmentoftherapeuticresistanceinthegliomaadoubleedgedsword
AT aligorji regulatoryroleofcircularrnasinthedevelopmentoftherapeuticresistanceinthegliomaadoubleedgedsword
AT taherehghadiri regulatoryroleofcircularrnasinthedevelopmentoftherapeuticresistanceinthegliomaadoubleedgedsword
AT safiehebrahimi regulatoryroleofcircularrnasinthedevelopmentoftherapeuticresistanceinthegliomaadoubleedgedsword